デフォルト表紙
市場調査レポート
商品コード
1724799

植込み型医療機器の市場規模、シェア、成長分析、製品別、タイプ別、機器の性質別、最終用途別、地域別 - 産業予測 2025~2032年

Implantable Medical Devices Market Size, Share, and Growth Analysis, By Product (Orthopedic, Cardiovascular), By Type (Treatment, Diagnostic), By Nature of Device, By End Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 165 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
植込み型医療機器の市場規模、シェア、成長分析、製品別、タイプ別、機器の性質別、最終用途別、地域別 - 産業予測 2025~2032年
出版日: 2025年05月07日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

植込み型医療機器の世界市場規模は2023年に974億米ドルとなり、予測期間(2025~2032年)のCAGRは6.9%で、2024年の1,041億2,000万米ドルから2032年には1,775億7,000万米ドルに成長する見通しです。

世界の植込み型医療機器市場は、慢性疾患率の上昇、高齢化、神経疾患や心血管疾患の蔓延に後押しされ、力強い成長を遂げています。積極的なインプラント医療技術の革新と洗練された製品開発のための投資の増加が、この拡大を後押ししています。さらに、医療用インプラントに対する意識の高まりや神経刺激アプリケーションの進歩も市場力学に寄与しています。しかし、移植コストの高さや熟練した専門家の不足などの課題もあります。とはいえ、革新的なインプラントソリューションへの幅広いアクセスを可能にする償還制度の充実が成長を支えています。市場が発展するにつれて、複雑な環境からの要求のバランスを図りながら、ライフサイクルを通じて機器の性能の寿命と有効性に対処していくことになります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術分析
  • 規制分析

植込み型医療機器市場規模:製品別& CAGR(2025-2032)

  • 市場概要
  • 整形外科
    • 関節再建
    • 脊椎デバイス
    • 外傷固定装置
    • その他の整形外科製品
  • 心血管系
    • ステント
    • 植込み型心臓除細動器(ICD)
    • ペースメーカー
    • 心臓再同期療法(CRT)
    • 心室補助装置
    • 埋め込み型心臓モニター(ICM)
    • その他の心血管製品
  • 歯科
  • 神経学
  • 眼科
  • 形成外科
  • その他の製品

植込み型医療機器市場規模:タイプ別& CAGR(2025-2032)

  • 市場概要
  • 治療
  • 診断

植込み型医療機器市場規模:機器の性質別& CAGR(2025-2032)

  • 市場概要
  • 静的/非能動的/受動的
  • 動的

植込み型医療機器市場規模:最終用途別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 外来手術センター
  • 多専門センター
  • クリニック
  • その他の最終用途

植込み型医療機器市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024年)

主要企業プロファイル

  • Medtronic(Ireland)
  • Abbott Laboratories(USA)
  • Boston Scientific Corporation(USA)
  • Johnson & Johnson(USA)
  • Stryker Corporation(USA)
  • Zimmer Biomet Holdings(USA)
  • Smith & Nephew plc(UK)
  • Becton, Dickinson and Company(USA)
  • Edwards Lifesciences(USA)
  • LivaNova(UK)
  • Globus Medical, Inc.(USA)
  • Alcon(Switzerland/USA)
  • Intuitive Surgical(USA)
  • B. Braun Melsungen AG(Germany)
  • Terumo Medical Corporation(Japan)
  • Dentsply Sirona(USA)
  • Koninklijke Philips N.V.(Netherlands)
  • BIOTRONIK SE & Co. KG(Germany)
  • Cochlear Limited(Australia)
  • Sonova Holding AG(Switzerland)

結論と提言

目次
Product Code: SQMIG35A2510

Global Implantable Medical Devices Market size was valued at USD 97.4 billion in 2023 and is poised to grow from USD 104.12 billion in 2024 to USD 177.57 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global implantable medical devices market is experiencing robust growth, fueled by rising chronic disease rates, an aging population, and the prevalence of neurological and cardiovascular disorders. Innovations in active implanted medical technologies and increased investments for developing sophisticated products are driving this expansion. Additionally, heightened awareness around medical implants and advancements in neurostimulation applications contribute to market dynamics. However, the industry faces challenges including high implantation costs and a lack of skilled professionals. Nevertheless, the growth is supported by enhanced reimbursement schemes, enabling broader access to innovative implant solutions. As the market evolves, it will seek to balance the demands of complex environments while addressing the longevity and effectiveness of device performance throughout their life cycles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Medical Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Medical Devices Market Segments Analysis

Global Implantable Medical Devices Market is segmented by Product, Type, Nature of Device, End Use and region. Based on Product, the market is segmented into Orthopedic, Cardiovascular, Dental, Neurology, Ophthalmology, Plastic surgery and Other products. Based on Type, the market is segmented into Treatment and Diagnostic. Based on Nature of Device, the market is segmented into Static/Non-active/Passive and Active. Based on End Use, the market is segmented into Hospitals, Ambulatory surgical centers, Multi-specialty centers, Clinics and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Medical Devices Market

The global implantable medical devices market is primarily driven by the growing prevalence of chronic diseases, including cardiovascular ailments, diabetes, and orthopedic issues. As the elderly population continues to expand worldwide, there is an escalating demand for advanced therapeutic solutions that incorporate implantable devices. This upward trend in chronic conditions, coupled with the aging demographic, significantly supports the growth of the market, emphasizing the necessity for innovative medical interventions to improve patient outcomes. The increasing reliance on sophisticated medical technology to manage these health challenges propels the development and adoption of implantable medical devices on a global scale.

Restraints in the Global Implantable Medical Devices Market

The global implantable medical devices market faces notable challenges due to the risk of complications and the possibility of device rejection by the body. Patients may experience adverse side effects, leading to increased healthcare costs and the need for additional medical procedures. Such risks can result in hesitation among both patients and healthcare providers when it comes to utilizing these devices. Consequently, this apprehension may hinder market growth, as stakeholders are concerned about the potential for complications that could compromise patient safety and lead to further medical interventions, thus impacting overall acceptance and adoption rates within the healthcare sector.

Market Trends of the Global Implantable Medical Devices Market

The global implantable medical devices market is witnessing a significant trend towards the integration of smart technologies, including advanced sensors and connectivity features. This evolution enables real-time monitoring of vital health indicators, allowing healthcare professionals to track patient parameters remotely. This shift not only enhances the quality of personalized care but also leads to improved healthcare outcomes by facilitating timely interventions and more effective disease management. As consumers and healthcare providers increasingly demand innovative solutions, the adoption of smart, connected implantable devices is poised to transform the landscape of medical treatment, driving market growth and fostering advancements in healthcare delivery.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Regulatory Analysis

Global Implantable Medical Devices Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Orthopedic
    • Joint reconstruction
    • Spinal devices
    • Trauma fixation devices
    • Other orthopedic products
  • Cardiovascular
    • Stents
    • Implantable cardiac defibrillators (ICDs)
    • Pacemaker
    • Cardiac resynchronization therapy (CRT)
    • Ventricular assist devices
    • Implantable cardiac monitors (ICM)
    • Other cardiovascular products
  • Dental
  • Neurology
  • Ophthalmology
  • Plastic surgery
  • Other products

Global Implantable Medical Devices Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Treatment
  • Diagnostic

Global Implantable Medical Devices Market Size by Nature of Device & CAGR (2025-2032)

  • Market Overview
  • Static/Non-active/Passive
  • Active

Global Implantable Medical Devices Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory surgical centers
  • Multi-specialty centers
  • Clinics
  • Other end use

Global Implantable Medical Devices Market Size & CAGR (2025-2032)

  • North America (Product, Type, Nature of Device, End Use)
    • US
    • Canada
  • Europe (Product, Type, Nature of Device, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Type, Nature of Device, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Type, Nature of Device, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Type, Nature of Device, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Globus Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcon (Switzerland/USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intuitive Surgical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Medical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dentsply Sirona (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOTRONIK SE & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cochlear Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonova Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations